Vaccines for children
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75D30122D13473
- Awardee
-
Pfizer Inc. UEI MHBQULRMEEJ5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Vaccines for Children Solicitation · 75D30122R72134 · Posted Jan 7, 2022
- Last date to order 100% complete
- IDV ceiling
- $1,517,947,500.00
- Maximum order
- $1,517,947,500.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. as the prime contractor. The contract has a ceiling value of $1,517,947,500.00 and a period of performance from April 1, 2022 through March 31, 2023. It is a multiple award contract vehicle that will provide up to 23 standard pediatric vaccines to support CDC's Immunization Awardees and the Vaccines for Children (VFC) program. The vaccines must have a minimum 12-month shelf life and be manufactured under a current FDA license. Vaccine quantities range from a minimum of 100 doses to a maximum of 13 million doses, depending on the type. The contract does not utilize any set-aside designations, as Pfizer is a large pharmaceutical manufacturer. The place of performance is within the United States, with vaccines to be shipped FOB destination to the 50 states and territories.
The original contract solicitation was posted on January 7, 2022, with offers due by January 21, 2022. It did not indicate any specific evaluation criteria. The contract aims to provide a wide range of pediatric vaccines, including those for diseases such as dengue, diphtheria, tetanus, pertussis, hepatitis, Haemophilus influenzae type b, human papillomavirus, measles, mumps, rubella, meningococcal disease, pneumococcal disease, rotavirus, and varicella. These vaccines are critical for supporting CDC's public health immunization efforts under Section 317(j) of the Public Health Service Act and the VFC program.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$3,038 | |
| Funding Only Action | $94,776,459 | |
| Funding Only Action | $213,861,543 | |
| Funding Only Action | $151,695,461 | |
| Funding Only Action | $274,281,374 | |
| Original award | $401,412,049 |
Quick answers
Who was awarded contract 75D30122D13473?
75D30122D13473 was awarded to Pfizer Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on April 1, 2022.
How much is contract 75D30122D13473 worth?
75D30122D13473's own ceiling is $1,517,947,500. A single order can be worth up to $1,517,947,500.
Who can order from contract 75D30122D13473?
75D30122D13473 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75D30122D13473 competed?
The extent of competition for 75D30122D13473 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV